Waddell & Associates’s Colgate-Palmolive CL Stock Holding History
Bought
Maintained
Sold
Other funds holding CL
SP
PAM
CIM
AAMU
JIC
WG
Waddell & Associates's CL Position: Q2 2026 in Review
Waddell & Associates increased its Colgate-Palmolive (CL) stake by 95% in Q2 2026, buying an estimated $197K and bringing the position to 4,627 shares worth $424K. The position accounts for 0.02% of the portfolio, ranked #306.
Waddell & Associates first reported a position in CL in Q2 2021 and has held it in 20 quarters since. The position peaked at $867K in Q3 2024. 658 funds tracked by Wall St. Rank hold CL as of Q2 2026.
- Waddell & Associates held 4,627 shares of Colgate-Palmolive worth $424K as of Q2 2026.
- Waddell & Associates bought 2,253 Colgate-Palmolive shares in Q2 2026, an estimated $197K.
- Colgate-Palmolive made up 0.02% of Waddell & Associates's portfolio in Q2 2026, its #306 holding.
- Waddell & Associates first reported a position in Colgate-Palmolive in Q2 2021 and has held it in 20 quarters since.
- Waddell & Associates's Colgate-Palmolive position peaked at $867K in Q3 2024.
- 658 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.
Based on Waddell & Associates's 13F filing for Q2 2026, filed 15 Jul 2026.